Skip to main content
Sandostatin LAR Depot (octreotide acetate for injectable suspension)
Support designed for patients and caregivers
  • Insurance and Medicare education to help you understand the insurance process

  • Financial assistance for eligible patients*

  • Patient Navigators who provide 1-on-1 support specific to your Novartis medicine(s)*

  • Information about independent organizations that can assist with your day-to-day needs beyond medical care

  • Patient Support Counselors who are able to provide information in over 160 languages

*Varies by product

Our Patient Assistance Now Oncology (PANO) program was created to assist with accessing your Novartis medicine(s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.

To learn more about what’s available, call 1-800-282-7630 or visit www.Patient.NovartisOncology.com/.


Mobile Administration Program

At your home, office, or destination—trained nurses can administer your injection

As a patient receiving Sandostatin® LAR Depot (octreotide acetate for injectable suspension) therapy, you know how important it is to keep to your regularly scheduled appointments and get your injections exactly as prescribed. That's why the Mobile Administration Program (MAP) was developed—to make coordinating your treatment a little easier.

If your doctor recommends you as an appropriate patient to participate in the program and you're eligible, you'll be able to receive your injections at home, at work, or while you're traveling, administered by a MAP nurse who is trained in the mixing and administration of Sandostatin LAR Depot. To take advantage of this convenient way to receive your injections:

  • Find out from your doctor if you're a candidate for MAP and check if you're eligible

  • Work with your doctor to complete the enrollment form

*Limitations apply. Program available only for patients with commercial insurance. Program not available for patients insured by Medicare, Medicaid, or any other federal or state program. Program not available for residents of Massachusetts, Michigan, Minnesota, or Rhode Island.

Download Enrollment Form


Important Things to Know About the Mobile Administration Program
  • MAP does not replace your doctor's care; you should still go to your regular doctor for checkups. MAP allows you to receive your injections at a time and location convenient for you

  • If you are new to Sandostatin LAR Depot, your first dose must be received in your doctor's office

 
What The Mobile Administration Program Offers
  • Receive Sandostatin (octreotide acetate) injections at convenient locations. When you're dealing with acromegaly, this program offers a convenient administration option

  • Your Sandostatin, your schedule. Nurses are available outside traditional office hours, including weekends, evenings, and even when you're traveling out of town

  • Receive Sandostatin injections from a trained professional. The MAP nurse will let your doctor know you have received your medicine (or injection). You will receive your Sandostatin injections at a location convenient for you

 
How the Mobile Administration Program Works

Just 4 Simple Steps to Receive Your Injections at Home

  1. Your doctor recommends you for the program and submits your enrollment form.

  2. Your eligibility is verified.

  3. You will receive a call to schedule your next injection at your convenience.

  4. A MAP nurse, who is specially trained in the mixing and administration of Sandostatin LAR Depot, meets you at a convenient time and place and gives the injection, makes the next appointment, following up with a reminder, and notifies your doctor that you received your injection.

 
Mobile Administration Program Eligibility

MAP is available to all eligible patients for whom Sandostatin LAR Depot has been prescribed for an FDA-approved indication.

  • Residents of all states except Massachusetts, Michigan, Minnesota, and Rhode Island can participate

  • MAP is available to eligible patients covered by most commercial plans (HMO, PPO, etc) generally available to patients with commercial insurance

  • The Program is not available for patients insured by Medicare, Medicaid, or other federal or state programs

  • Print the enrollment form and discuss with your doctor if you're a candidate for MAP


Frequently Asked Questions

Mobile Administration Program For Eligible Patients

The Mobile Administration Program (MAP) is generally available to commercially insured patients for whom Sandostatin LAR has been prescribed for an FDA-approved indication. The Program is not available for residents of Massachusetts, Michigan, Minnesota, or Rhode Island.

Important Safety Information

Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of gallstones resulting in complications...

Approved Uses

Sandostatin® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin® ...

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USES